跳至主要内容
临床试验/NCT01552876
NCT01552876已完成不适用

Comparative Clinical Evaluation of Soft Toric Lens Designs

Johnson & Johnson Vision Care, Inc.1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2012年2月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
1
主要终点
Phase I: Absolute Lens Rotation

研究概览

简要总结

This study is evaluating the initial fit of toric contact lenses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be greater than or equal to 18 years old.
  • Read, understand, and sign written Statement of Informed Consent.
  • Appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • Be existing soft contact lens wearers (no extended wear in the last 3 months, but silicone hydrogels in daily wear are allowed).
  • Require a visual correction in both eyes (monovision allowed but no monofit).
  • Have a spherical contact lens requirement in the range -0.50D to -6.00D.
  • Have astigmatism of between -0.50 and -2.00DC in both eyes.
  • Monocular distance visual acuity correctable to 6/9 (0.2 logMAR) or better in each eye with best sphero-cylindrical refraction.
  • Have normal eyes with no evidence of any ocular abnormality or disease. For the purposes of this study a normal eye is defined as one having: Clear cornea, No anterior segment disorder, No clinically significant slit lamp findings (i.e. oedema, staining, scarring, vascularisation, infiltrates or abnormal opacities), No other active ocular disease or recent surgery

排除标准

  • Having worn RGP contact lenses within the last 30 days or PMMA contact lenses within the last 3 months.
  • Clinically significant corneal oedema, corneal vascularisation, corneal staining, tarsal abnormalities, bulbar injection or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Extended lens wear in last 3 months.
  • Any systemic or topical medications that will in the investigator's opinion affect ocular physiology or contact lens performance.
  • Any systemic disease affecting ocular health.
  • Abnormal lacrimal secretions.
  • Keratoconus or other corneal irregularity.
  • Pregnancy, lactating or planning a pregnancy at the time of enrolment.
  • Participation in any concurrent clinical trial.
  • Any previous anterior ocular surgery.
  • Subjects who are known to have an infectious systemic disease (e.g., hepatitis, tuberculosis).
  • Subjects who are known to have an immunosuppressive disease (e.g., HIV positive).
  • Subjects who are known to have diabetes.
  • Employees or family members of the Research site, Principal Investigator or study team.

研究组 & 干预措施

etafilcon A / nelfilcon A / Filcon II 3

Other

etafilcon A worn first then nelfilcon A worn second with Filcon II 3 worn third.

干预措施: Filcon II 3 (Device)

etafilcon A / nelfilcon A / Filcon II 3

Other

etafilcon A worn first then nelfilcon A worn second with Filcon II 3 worn third.

干预措施: etafilcon A (Device)

etafilcon A / nelfilcon A / Filcon II 3

Other

etafilcon A worn first then nelfilcon A worn second with Filcon II 3 worn third.

干预措施: nelfilcon A (Device)

nelfilcon A / etafilcon A / Filcon II 3

Other

nelfilcon A worn first then etafilcon A worn second with Filcon II 3 worn third.

干预措施: etafilcon A (Device)

nelfilcon A / etafilcon A / Filcon II 3

Other

nelfilcon A worn first then etafilcon A worn second with Filcon II 3 worn third.

干预措施: nelfilcon A (Device)

nelfilcon A / etafilcon A / Filcon II 3

Other

nelfilcon A worn first then etafilcon A worn second with Filcon II 3 worn third.

干预措施: Filcon II 3 (Device)

结局指标

主要结局

Phase I: Absolute Lens Rotation

时间窗: 3 min after lens insertion during Phase I

Lens orientation position as assessed on a scale of 0-180 on both eyes.

次要结局

  • Phase I: Time to Lens Settling(5 minutes after lens insertion during Phase I)
  • Phase I: Number of Blinks Until Settled(Baseline to 5 minutes during Phase I)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验